Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the brain tumor study group
Mark G. Malkin(Cleveland Clinic), John C. Van Gilder(University of Iowa), Thomas A. Strike(Unknown), M. S. Mahaley, Joseph Ransohoff, John Mealey, Sylvan B. Green(National Institutes of Health), David Pistenmaa(Memorial Sloan Kettering Cancer Center), James T. Robertson(University of Salford), David P. Byar(National Cancer Institute), F. Stephen Vogel(Washington University Medical Center), Peter C. Burger, William R. Shapiro(National Institutes of Health), Robert G. Selker(Memorial Sloan Kettering Cancer Center)
Cited by 9
Related Papers
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
|Neurology|1991|5.1k
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
|Journal of neurosurgery|1978|1.7k
Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery
|New England Journal of Medicine|1980|1.6k
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study
|JAMA|1995|1.3k
The Molecular Basis of Turcot's Syndrome
|New England Journal of Medicine|1995|1.1k